Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1678 S Pioneer Rd SALT LAKE CITY UT 84104-4205 |
Tel: | 1-801-9731566 |
Website: | https://www.vareximaging.com |
IR: | See website |
Key People | ||
Sunny S. Sanyal President, Chief Executive Officer, Director | Shubham Maheshwari Chief Financial Officer | Kimberley E. Honeysett Senior Vice President, Chief Legal Officer, General Counsel, Corporate Secretary |
Andrew Hartmann Senior Vice President, General Manager - Detectors | Mark S. Jonaitis Senior Vice President, General Manager - X-Ray Sources |
Business Overview |
Varex Imaging Corporation is a designer and manufacturer of X-ray tubes, digital detectors and other image processing solutions. The Company operates through two segments: Medical and Industrial. The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, three-dimensional (3D) reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications. The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in various other markets. |
Financial Overview |
For the 26 weeks ended 29 March 2024, Varex Imaging Corp revenues decreased 9% to $396.2M. Net income decreased 88% to $900K. Revenues reflect Medical segment decrease of 14% to $288.7M, APAC segment decrease of 19% to $127.9M, United States segment decrease of 11% to $124.7M. Net income also reflects Selling, General & Administrative increase of 4% to $62.8M (expense), Stock-based Compensation in SGA increase of 28% to $5.1M (expense). |
Employees: | 2,300 as of Mar 29, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $888.75M as of Mar 29, 2024 |
Annual revenue (TTM): | $877.80M as of Mar 29, 2024 |
EBITDA (TTM): | $102.20M as of Mar 29, 2024 |
Net annual income (TTM): | $44.60M as of Mar 29, 2024 |
Free cash flow (TTM): | $96.80M as of Mar 29, 2024 |
Net Debt Last Fiscal Year: | $255.80M as of Mar 29, 2024 |
Shares outstanding: | 40,900,000 as of Apr 25, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |